Drug Development in Dementia

Dementia is a progressive, irreversible decline in cognition that, by definition, impacts on a patient pre-existing level of functioning. The clinical syndrome of dementia has several aetiologias of which Alzheimer’s disease (AD) is the most common. Drug development in AD is based on evolving pathophysiological theory. Disease modifying approaches include the targeting of amyloid processing, aggregation of tau, insulin signaling, neuroinflammation and neurotransmitter dysfunction, with efforts thus far yielding abandoned hopes and on-going promise. Reflecting its dominance on the pathophysiological stage the amyloid cascade is central to many of the emerging drug therapies.

    Related Conference of Drug Development in Dementia

    October 24-25, 2019

    31st International Conference on Psychiatry & Mental Health

    Helsinki, Finland
    November 07-08, 2019

    13th Global Neurologists Meeting on Neurology and Neurosurgery

    Frankfurt, Germany
    November 07-08, 2019

    19th Global Neuroscience and Neurology Conference

    Frankfurt, Germany
    November 11-12, 2019

    International Conference on Stress and Mental Health

    Sydney, Australia
    November 14-15, 2019

    13th International Conference on Alzheimer’s Disease & Dementia

    Holiday Inn Paris - Porte de Clichy, Paris | France
    November 18-19, 2019

    2ndInternational Congress on Neurology and Psychology

    | Holiday Inn Rome - Aurelia | Rome, Italy
    November 21-22, 2019

    12th Annual Brain Death Congress

    Zagreb, Croatia
    November 22 & 23, 2019

    International Conference on Bipolar Disorder & Depression

    | Nice, France

    Accredited with CPD
    November 25-26, 2019

    Experts meet on Stress Management

    Auckland, NewZealand
    November 25-26, 2019

    2nd World Congress on Addiction and Rehabilitation

    Paris, France
    December 04-05, 2019

    World Congress on Neurochemistry & Neuropharmacology

    Istanbul, Turkey
    January 16-17, 2020

    International Summit on Mental Disorders and Illness

    Lisbon, Portugal
    January 16-17, 2020

    Global Submit on Neurology and Neurosurgery

    Lisbon | Portugal
    January 23-24, 2020

    12th World Congress on Alzheimers Disease & Dementia

    Bangkok, Thailand
    February 10-11, 2019

    Global Experts Meet on STD-AIDS and Infectious Diseases

    Sydney, Australia
    February 24-25, 2020

    29th World Congress on Neurology and Therapeutics

    London, UK
    March 30-31, 2020 |

    Global Experts Meet on Neurology and Neuropsychiatry

    Kyoto, Japan
    June 22-23, 2020

    12th International Conference on Vascular Dementia

    Prague | Czech Republic
    June 24-25, 2020

    34th European Neurology Congress

    Zurich, Switzerland
    June 29-30, 2020

    12th World Congress on Neuropharmacology

    Athens, Greece
    July 13-14, 2020

    32nd International Conference on Pediatric Nursing

    Sydney, Australia
    August 17-18-2020

    10th International Conference on Brain Injury & Neuroscience

    Copenhagen, Denmark
    September 20-21, 2020

    6th International Conference on Epilepsy & Treatment

    Rome, Italy
    October 05-06, 2020

    6th European Otolaryngology-ENT Surgery Conference

    Vienna, Austria
    October 12-13, 2020

    27thNeuropharmacology Congress

    Zurich, Switzerland
    October 12-13, 2020

    Heart-Brain-cs-2020

    London, UK
    October 26-27, 2020

    World Congress on Nutrition & Eating Disorders

    Tokyo, Japan
    November 23-24, 2020

    6th Global Meetings on Pharmaceutical Chemistry

    London, UK

    Drug Development in Dementia Conference Speakers